Drug intelligence / Profile preview

lidocaine + prilocaine + bupivacaine

Development stage
Phase 3
Lead developer
Federal University of São Paulo
Modality
Small Molecules
Administration
Topical
01

Overview

lidocaine + prilocaine + bupivacaine is a topical eutectic mixture of three local anesthetics being investigated for the management of postoperative pain, specifically following hemorrhoidectomy. Developed by researchers at the Federal University of São Paulo, this combination therapy leverages the different pharmacokinetic profiles of its components: lidocaine and prilocaine provide a rapid onset of action, while bupivacaine offers a more prolonged duration of analgesia. The mixture acts by binding to and blocking voltage-gated sodium channels on the internal surface of nerve cell membranes. This action prevents the influx of sodium ions, thereby inhibiting the depolarization of the neuronal membrane and the subsequent propagation of pain signals from the surgical site to the central nervous system.

Other names
Eutectic mixture of lidocaine, prilocaine, and bupivacaine
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)SCN10A (Sodium channel protein type X alpha subunit)SCN11A (NaV1.9)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)SCN3A (Sodium channel protein type 3 subunit alpha)SCN4A (Voltage-gated sodium channel protein type 4 subunit alpha)SCN5A (Sodium channel protein type 5 subunit alpha)SCN8A (NaV1.6)SCN9A (Sodium channel protein type 9 subunit alpha)

Beyond the preview

Go deeper on lidocaine + prilocaine + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + prilocaine + bupivacaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call